WuXi AppTec (OTCMKTS:WUXAY) Reaches New 1-Year High – Still a Buy?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) reached a new 52-week high on Tuesday . The stock traded as high as $27.08 and last traded at $27.08, with a volume of 121 shares traded. The stock had previously closed at $25.41.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Strong Buy”.

WuXi AppTec Stock Performance

The firm’s fifty day simple moving average is $23.69 and its 200 day simple moving average is $18.87.

WuXi AppTec Company Profile

WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.

The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.

Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.